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Objective : To investigate serum marker which are correlated with
the low bone mineral density (BMD) in old aged (65 years) Korean
women.
Methods : Medical records of 154 postmenopausal women aged over
65 years who visited health care clinic of our hospital were reviewed
retrospectively. We investigated women's baseline characteristics
including age, height, weight, body mass index (BMI) and laboratory
findings including serum lipid profile, thyroid hormone, calcium,
phosphorus, bone alkaline phosphatase. Bone mineral density
(BMD) was measured with DXA (Prodigy; GE-lunar, Houston, TX,
USA). The correlation between laboratory test result and BMD was
analyzed using R statistical package (version 2.13.1).
Results : Mean age was 69.77± 6.45 years and mean BMI was
24.46± 3.63(kg/m2). The low BMD including osteoporosis and
osteopenia was significantly associated with age, Triiodothyronine
(T3) and HDL-cholesterol level. The low femur BMD was associated
with serum HDL-cholesterol level. The lumbar BMD was signifi-
cantly correlated with serum-cholesterol, HDL.. T3 was negatively
correlated with lumbar and femur BMD and T4 was negatively corre-
lated with femur BMD. TSH was no significant relationship with
BMD.
Conclusion : The levels of serum HDL-cholesterol and T3 could be
used as indirect markers for low BMD in old aged women.
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Bone Densitometry Service and the Post-fracture Care Gap in Hong
Kong: How Bad is the Situation.
W.H.A. Ho, S.H. Wong, Caritas Medical Centre, Hong Kong, Hong
Kong
Introduction: Patients who sustain an osteoporotic fracture are at
increased risk of sustaining further osteoporotic fracture. There are
international guidelines to close this post-fracture care gap but not
in Hong Kong. Older patients presenting with fractures should be
offered assessment for osteoporosis by axial bone densitometry. We
report the current situation and practice of using bone densitometry
assessment after osteoporotic hip fracture.
Methods: We retrieved patients with new osteoporotic hip fractures
age 65 or above with DXA performed within one year after fracture,
admitted from 1st Jan 2012 to 30th June 2014 using Hospital Author-
ity CDARS.
Results: 11397 osteoporotic hip fracture patients were included. Only
398 patients (3.49%) received DXA within one year after fracture.
Among the group with DXA performed, 69% were from two Hospi-
tals. The other 11 hospitals contribute the remaining 31%.
Discussion and conclusion: There is a huge post-fracture care gap in
secondary prevention for osteoporotic hip fracture patient in Hong
Kong. Majority of the patients in Hong Kong are neither diagnosednor being tested for osteoporosis and remained untreated. The Gov-
ernment needs to allocate more resources to implement the best prac-
tices framework to those high risk post-hip fracture patients before
they go on to break another bone. By reducing the number of subse-
quent osteoporotic fractures, the Government can get significant cost
savings that can be utilized in other valuable healthcare program.
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Fracture Risk of Adjuvant Therapies in Young Breast Cancer
Patients: A Population-Based Study
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Introduction: Breast cancer survivors have an increased risk of
bone fracture. But the risk among young patients with adjuvant
therapies remains unknown. This population-based study is aimed
to assess the incidence and risk of fracture among young (age of
20 to 39 years) breast cancer patients who received adjuvant
therapies.
Materials and Methods: From January 2001 to December 2007,
5,146 newly diagnosed breast cancer patients were enrolled from
the National Health Insurance Research Database (NHIRD) in Tai-
wan. Patients were observed for a maximum of 6 years to determine
the incidence of newly onset fracture. Kaplan Meier and Cox regres-
sion analyses were used to evaluate the risk of fracture in young
breast cancer patients who received adjuvant treatments.
Results: Of the total 5,146 young (age of 20 to 39 years) breast can-
cer patients, the Cox multivariate proportional hazards analysis
showed that AIs, radiotherapy, and monoclonal antibodies were sig-
nificantly associated with a high risk of fracture. Moreover, patients
who received AIs for more than 180 days had a high hazard ratio
(HR) of 1.77 (95% CI¼ 0.68e4.57), and patients who received
more than four radiotherapy visits had a high HR of 2.54 (95%
CI¼ 1.07e6.06). Under the site-specific analysis, young breast can-
cer patients who received AIs had the highest risk of hip fracture
(HR¼ 8.520, 95% CI¼ 1.711e42.432, p< 0.04), whereas patients
who received radiotherapy had the highest risk of vertebral fracture
(HR¼ 5.512, 95% CI¼ 1.847e16.451, p< 0.01).
Discussion/Conclusions: Young breast cancer patients who are
receiving AIs, radiotherapy or monoclonal antibody need to be
more careful for preventing fracture events. Breast cancer treat-
ment plans are suggested to incorporate fracture prevention inter-
ventions.
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The Effect of Cemented and Uncemented Implants on the Measure-
ment of Proximal Femur BMD
Yue Ding, Guangtao Fu, Changchuan Li, Wei Liu, Sun Yat-Sen
University Sun Yat-Sen Memorial Hospital, GuangZhou, China
Objective: The study was performed to test the hypothesis that
cemented and uncemented implants influenced the measurement of
proximal femur BMD.
Methods: 10 patients underwent THAwith cemented or uncemented
implants due to developmental dysplasia of the hip, femoral neck
fracture or femoral head necrosis from January 2015 to July 2015
were included. The patients' BMD of L1-L4 and femoral neck were
measured preoperative. We measured the BMD of proximal femur
